See What HealthDay Can Do For You
Contact Us

Four Methods Can Diagnose Fetal Nasal Bone Hypoplasia

Similar sensitivity for all methods for identifying fetal NB hypoplasia in second trimester

doctor and patient

THURSDAY, Jan. 21, 2016 (HealthDay News) -- Four methods can be used for diagnosing fetal nasal bone (NB) hypoplasia in the second trimester in order to predict Down's syndrome, according to a study published online in the February issue of the Journal of Clinical Ultrasound.

Recep Has, M.D., from Istanbul University, and colleagues examined the best method for use in diagnosing fetal NB hypoplasia in the second trimester as a means of predicting trisomy 21. They calculated and compared NB length (NBL), NBL percentiles, NBL multiple-of-median (MoM) values, and biparietal diameter-to-NBL ratios, and assessed predictive values for several cut-off points using data from 1,689 fetuses.

The researchers found that NBL had 25.5 percent sensitivity using a fixed 5 percent false-positive rate. Sensitivity for NBL percentiles, NBL MoM values, and biparietal diameter-to-NBL ratios was 23.5 percent.

"Our study demonstrated that all four methods can be used in the second trimester for diagnosing fetal NB hypoplasia as a means of predicting trisomy 21 because their predictive values are similar at a fixed 5 percent false-positive rate," the authors write. "For simplicity of use, we recommend using 3 mm as the NBL cut-off value."

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.